Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Decline in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a significant drop in short interest during the month of May. As of May 29th, there was short interest totaling 2,772 shares, a drop of 67.1% from the May 14th total of 8,438 shares. Based on an average trading volume of 7,331 shares, the short-interest ratio is presently 0.4 days.

Analysts Set New Price Targets

Separately, Zacks Research cut shares of Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a report on Monday, May 25th. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold”.

Carl Zeiss Meditec Stock Performance

Shares of Carl Zeiss Meditec stock traded down $0.17 during trading on Friday, reaching $28.97. The company’s stock had a trading volume of 857 shares, compared to its average volume of 5,087. The company has a 50-day moving average price of $30.44 and a two-hundred day moving average price of $35.81. Carl Zeiss Meditec has a fifty-two week low of $26.65 and a fifty-two week high of $72.57.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.